4.2 Article

TEL/PDGFβR fusion protein activates STAT1 and STAT5:: A common mechanism for transformation by tyrosine kinase fusion proteins

期刊

EXPERIMENTAL HEMATOLOGY
卷 28, 期 5, 页码 584-593

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/S0301-472X(00)00138-7

关键词

TEL/PDGF beta R; tyrosine kinases; STAT5; CMML

资金

  1. NCI NIH HHS [K08CA73749-01] Funding Source: Medline
  2. NIDDK NIH HHS [P01DK50654-01] Funding Source: Medline

向作者/读者索取更多资源

Objective. TEL/PDGF beta R is a tyrosine kinase fusion protein associated with the pathogenesis of chronic myelomonocytic leukemia, The following experiments were undertaken to understand the mechanisms whereby TEL/PDGF beta R transforms cells. Materials and Methods. Activation of JAK: and STAT proteins was studied in an interleukin 3 (IL3)-dependent cell line, Ba/F3, transformed to IL-3 independence by TEL/PDGF beta R. Results. TEL/PDGF beta R activates STAT1 and STAT5 in transformed Ba/F3 cells through a JAK-independent pathway. Activation of STAT proteins requires the kinase activity of TEL/PDGF beta R, JAK1, JAK2, JAK3, and TYK2 are not phosphorylated by TEL/PDGR beta R. However, TEL/PDGF beta R can phosphorylate STAT5 in transiently transfected COS tells, suggesting that TEL/PDGF beta R may itself be the kinase involved in tyrosine phosphorylation of STAT proteins. In contrast, native PDGF beta R stimulated by PDGF ligand does not activate STAT proteins to a significant degree in this hematopoietic context. STAT1 and STAT5 also are activated by TEL/ABL and TEL/JAK2. fusion proteins associated with human leukemia, Conclusions. STAT activation may be a common mechanism of transformation by leukemogenic tyrosine kinase fusion proteins. (C) 2000 International Society for Experimental Hematology. Published by Elsevier Science Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据